Table: Kaken Pharmaceutical -2015/16 group results

KAKEN PHARMACEUTICAL

12/05/2016 05:30

May 12 (Reuters)-  
          Kaken Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          109.73           93.89         106.10        52.70     
               (+16.9 pct)     (+5.6 pct)     (-3.3 pct)    (-4.1 pct)  
  Operating       35.15           20.63          28.90        14.10     
               (+70.4 pct)     (+30.0 pct)    (-17.8 pct)  (-23.6 pct)  
  Recurring       35.37           20.39          29.10        14.20     
               (+73.4 pct)     (+31.4 pct)    (-17.7 pct)  (-23.5 pct)  
  Net 
  Net             21.14           12.12          20.80        10.00     
               (+74.4 pct)     (+24.5 pct)    (-1.6 pct)   (-19.9 pct)  
  EPS          510.54 yen      290.90 yen     502.34 yen    241.51 yen  
  Ann Div                       59.00 yen     150.00 yen                
  -Q2 Div       34.00 yen       27.00 yen      75.00 yen                
  -Q4 Div       78.00 yen       32.00 yen      75.00 yen                
   
  NOTE - Kaken Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T 
  ((Tokyo Headline News Desk +813 6441 1812))